Boehringer Ingelheim Innovation Prize

The award provides a platform to show-case ideas and projects from entrepreneurs and start-up organizations. Shortlisted applicants are invited to present their ideas in a poster session, from which a final short-list is selected to pitch their ideas to a panel of judges. Our most recent winner, Fairbanks Pharmaceuticals, was recognized for its work in developing transformative therapies that address the underlying cause of diabetes. Other winners include AbeXXa Biologics, an immune-oncology company; RIFT Biotherapeutics, a therapeutic antibody company focused on immuno-oncology targets outside of the T-cell space; and Kleo Pharmaceuticals, winners of the first Innovation prize in 2015, in recognition of its work in developing small molecule immunotherapies.

Please look at our calendar to find events in your location and watch this space for more information!

“Boehringer Ingelheim recognizes the innovation power of entrepreneurs and bio-entrepreneurs to create and sustain pipelines for the next-generation of medicines. Our Innovation Prize is in recognition of the challenges and dedication it takes to start new companies, and we are in constant admiration of innovators willing to take the risk to bring their ideas to market.”

Dr. Ioannis Sapountzis, Global Head, Business Development and Licensing